Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Inventory (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Inventory readings, the most recent being $128.8 million for Q4 2025.

  • On a quarterly basis, Inventory fell 13.93% to $128.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $128.8 million, a 13.93% decrease, with the full-year FY2025 number at $128.8 million, down 13.93% from a year prior.
  • Inventory hit $128.8 million in Q4 2025 for Tandem Diabetes Care, down from $137.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $161.7 million in Q2 2024 to a low of $65.7 million in Q3 2021.
  • Median Inventory over the past 5 years was $134.4 million (2023), compared with a mean of $120.0 million.
  • Biggest five-year swings in Inventory: soared 67.54% in 2023 and later dropped 13.93% in 2025.
  • Tandem Diabetes Care's Inventory stood at $68.6 million in 2021, then surged by 62.09% to $111.1 million in 2022, then surged by 42.14% to $157.9 million in 2023, then decreased by 5.27% to $149.6 million in 2024, then dropped by 13.93% to $128.8 million in 2025.
  • The last three reported values for Inventory were $128.8 million (Q4 2025), $137.3 million (Q3 2025), and $142.6 million (Q2 2025) per Business Quant data.